This webinar delves into the intricate world of SARS-CoV-2 glycosylation through mass spectrometry analysis, with Dr. Marshall Bern, Professor Max Crispin, and Dr Joel Allen. We explore the pivotal role of glycosylation in the structural and functional analysis of viral proteins. Dr. Bern a co-founder of Protein Metrics, shares his groundbreaking work in mass spectrometry software development, enhancing our understanding of protein modifications. Professor Crispin, from the University of Southampton, discusses his lab’s focus on glycoprotein therapeutics, shedding light on glycan analysis and its implications for vaccine design. Joel Allen, transitioning from the Oxford GlycoBiology Institute to Southampton, brings his expertise in viral glycan shields, particularly from his studies on HIV, to this pressing research on coronavirus.

This session is a comprehensive overview of current methodologies and analytical workflows employed in glycosylation studies, highlighting the integration of advanced mass spectrometry techniques. This webinar not only enhances our understanding of SARS-CoV-2’s glycan shield but also provides valuable insights into the broader implications of glycosylation in therapeutic development. Join us as we unravel the complexities of viral proteins through the lens of glycosylation, aiming to inform and innovate in the fight against global health threats.